Literature DB >> 16781460

Cathepsin B is a differentiation-resistant target for nitroxyl (HNO) in THP-1 monocyte/macrophages.

Antti J Väänänen1, Pertteli Salmenperä, Mika Hukkanen, Pekka Rauhala, Esko Kankuri.   

Abstract

We previously showed that the one-electron reduction product of nitric oxide (NO), nitroxyl (HNO), irreversibly inhibits the proteolytic activity of the model cysteine protease papain. This result led us to investigate the differential effects of the nitrogen oxides, such as nitroxyl (HNO), NO, and in situ-generated peroxynitrite on cysteine modification-sensitive cellular proteolytic enzymes. We used Angeli's salt, diethylaminenonoate (DEA/NO), and 3-morpholinosydnoniminehydrochloride (SIN-1), as donors of HNO, NO, and peroxynitrite, respectively. In this study we evaluated their inhibitory activities on the lysosomal mammalian papain homologue cathepsin B and on the cytosolic 26S proteasome in THP-1 monocyte/macrophages after LPS activation or TPA differentiation. HNO-generating Angeli's salt caused a concentration-dependent (62 +/- 4% at 316 muM) inhibition of the 26S proteasome activity, resulting in accumulation of protein-bound polyubiquitinylated proteins in LPS-activated cells, whereas neither DEA/NO nor SIN-1 showed any effect. Angeli's salt, but not DEA/NO or SIN-1, also caused (94 +/- 2% at 316 muM) inhibition of lysosomal cathepsin B activity in LPS-activated cells. Induction of macrophage differentiation did not significantly alter the inhibitory effect of HNO on lysosomal cathepsin B activity, but protected the proteasome from HNO-induced inhibition. The protection awarded by macrophage differentiation was associated with induction of the GSH synthesis rate-limiting enzyme gamma-glutamylcysteine synthetase, as well as with increased intracellular GSH. In conclusion, HNO abrogates both lysosomal and cytosolic proteolysis in THP-1 cells. Macrophage differentiation, associated with upregulation of antioxidant defenses such as increased cellular GSH, does not protect the lysosomal cysteine protease cathepsin B from inhibition.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16781460     DOI: 10.1016/j.freeradbiomed.2006.03.016

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  8 in total

Review 1.  The pharmacology of nitroxyl (HNO) and its therapeutic potential: not just the Janus face of NO.

Authors:  Nazareno Paolocci; Matthew I Jackson; Brenda E Lopez; Katrina Miranda; Carlo G Tocchetti; David A Wink; Adrian J Hobbs; Jon M Fukuto
Journal:  Pharmacol Ther       Date:  2006-11-29       Impact factor: 12.310

Review 2.  The emergence of nitroxyl (HNO) as a pharmacological agent.

Authors:  Christopher H Switzer; Wilmarie Flores-Santana; Daniele Mancardi; Sonia Donzelli; Debashree Basudhar; Lisa A Ridnour; Katrina M Miranda; Jon M Fukuto; Nazareno Paolocci; David A Wink
Journal:  Biochim Biophys Acta       Date:  2009-05-06

3.  Glutathione sulfinamide serves as a selective, endogenous biomarker for nitroxyl after exposure to therapeutic levels of donors.

Authors:  Gail M Johnson; Tyler J Chozinski; Elyssia S Gallagher; Craig A Aspinwall; Katrina M Miranda
Journal:  Free Radic Biol Med       Date:  2014-07-23       Impact factor: 7.376

4.  Analysis of the HNO and NO donating properties of alicyclic amine diazeniumdiolates.

Authors:  Gaurav Bharadwaj; Patricia G Z Benini; Debashree Basudhar; Cyf N Ramos-Colon; Gail M Johnson; Marti M Larriva; Larry K Keefer; Daniela Andrei; Katrina M Miranda
Journal:  Nitric Oxide       Date:  2014-09-02       Impact factor: 4.427

Review 5.  The chemical biology of HNO signaling.

Authors:  Christopher L Bianco; John P Toscano; Michael D Bartberger; Jon M Fukuto
Journal:  Arch Biochem Biophys       Date:  2016-08-20       Impact factor: 4.013

6.  Quantification of intracellular HNO delivery with capillary zone electrophoresis.

Authors:  Thilini N Amarakoon; Neng Ke; Craig A Aspinwall; Katrina M Miranda
Journal:  Nitric Oxide       Date:  2021-10-27       Impact factor: 4.427

7.  Direct Ink Writing of Biocompatible Nanocellulose and Chitosan Hydrogels for Implant Mesh Matrices.

Authors:  Rubina Ajdary; Guillermo Reyes; Jani Kuula; Eija Raussi-Lehto; Tomi S Mikkola; Esko Kankuri; Orlando J Rojas
Journal:  ACS Polym Au       Date:  2021-12-10

Review 8.  Nitroxyl (HNO): A Reduced Form of Nitric Oxide with Distinct Chemical, Pharmacological, and Therapeutic Properties.

Authors:  Mai E Shoman; Omar M Aly
Journal:  Oxid Med Cell Longev       Date:  2015-12-07       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.